12,7500 zł
-1,92%
-0,2500 zł
Akcjonariat - SOPHARMA
Dane ogólne
| Kapitalizacja: | 2 291 419 812,75 | Liczba dużych akcjonariuszy: | 3 |
| Liczba akcji: | 179 719 201 | Liczba akcji w posiadaniu dużych akcjonariuszy: | 111 444 563 |
| Liczba głosów na WZA: | 179 719 201 | Procent akcji w posiadaniu dużych akcjonariuszy: | 62,01% |
| Kapitał akcyjny: | 179 719,00 | Liczba głosów w posiadaniu dużych akcjonariuszy: | 111 444 563 |
| Cena nominalna akcji: | 0,00 | Procent głosów w posiadaniu dużych akcjonariuszy: | 62,01% |
| Rozwodniona liczba akcji: | - | Free float: | 37,99% |
Najwięksi akcjonariusze
| Nazwa | Uwagi | Liczba akcji | Liczba głosów | Data zmiany | Udziały w innych spółkach |
|---|---|---|---|---|---|
| Donev Investments Holding AD | 69 122 526 (38,46%) | 69 122 526 (38,46%) | 2024-06-14 | - | |
| Telekomplekt AD | 27 876 206 (15,51%) | 27 876 206 (15,51%) | 2020-12-30 | - | |
| Sopharma AD | 20 147 579 (11,21%) | 20 147 579 (0,00%) | 2025-09-04 | - | |
| Donev, Ognian Ivanov | 14 445 831 (8,03%) | 14 445 831 (8,03%) | 2024-06-14 | - |
Emisje
| Opis | Data WZA | Emisja | Cena nominalna | Cena emisyjna | Kapitał po emisji (liczba akcji w tys. szt. / wartość w tys. zł) | Data | |
|---|---|---|---|---|---|---|---|
| akcje zwykłe cena nominalna w BGN | 132 000 000 |
1,00 | 132 000 000 132 000 000,00 |
KDPW: KRS: GPW: |
2011-11-28 |
||
| akcvj zwykłe | 7 128 623 |
0,00 | 179 719 201 179 719,00 |
KDPW: KRS: GPW: |
2025-06-30 |
||
| połączenie z Medica AD bez podwyższania kapitału | KDPW: KRS: GPW: |
2017-04-25 |
|||||
| emisja połączeniowa akcjonariusze Bulgarian Rose-Sevtopolis AD | 2015-01-09 | 2 797 899 |
1,00 | 134 797 899 134 797 899,00 |
KDPW: KRS: GPW: |
2015-02-26 |
|
| połączenie z Unipharm AD bez podwyższania kapitału, odwołane | 2018-02-23 | KDPW: KRS: GPW: |
|||||
| połączenie z Unipharm AD bez podwyższania kapitału | 2018-08-01 | KDPW: KRS: GPW: |
2018-09-13 |
||||
| akcje zwykłe za warranty | 2023-06-02 | 37 792 679 156 083 764,27 |
1,00 | 4,13 | 172 590 578 172 590 578,00 |
KDPW: KRS: GPW: |
2023-10-06 |
| połączenie z Biopharm-engineering AD bez podwyższania kapitału | 2023-08-04 | KDPW: KRS: GPW: |
2023-08-23 |
||||
| akcje zwykłe | 2024-01-26 | 7 133 264 29 460 380,32 |
1,00 | 4,13 | KDPW: KRS: GPW: |
||
| połączenie z Veta Pharma AD bez podwyższania kapitału | 2024-08-08 | KDPW: KRS: GPW: |
|||||
| akcje zwykłe za warranty subskrypcyjne | 2024-10-14 | 623 779 2 576 207,27 |
1,00 | 4,13 | KDPW: KRS: GPW: |
||
| akcje zwykłe | 2025-06-27 | 359 438 402 |
1,00 | KDPW: KRS: GPW: |
|||
Zmiany akcjonariatu
| Nazwa | Uwagi | Liczba akcji | Procent akcji | Liczba głosów | Procent głosów | Data operacji |
|---|---|---|---|---|---|---|
| Sopharma AD | 20 215 279 (-13 400) | 11,24 (-0,01) | 20 215 279 (-13 400) | 0,00 | 2025-09-03 | |
| Sopharma AD | 20 228 679 (-9 890) | 11,25 (-0,01) | 20 228 679 (-9 890) | 0,00 | 2025-09-02 | |
| Sopharma AD | 20 238 569 (-56 195) | 11,26 (-0,03) | 20 238 569 (-56 195) | 0,00 | 2025-09-01 | |
| Sopharma AD | 20 294 764 (-94 677) | 11,29 (-0,05) | 20 294 764 (-94 677) | 0,00 | 2025-08-29 | |
| Sopharma AD | 20 389 441 (-62 500) | 11,34 (-0,03) | 20 389 441 (-62 500) | 0,00 | 2025-08-28 | |
| Sopharma AD | 20 451 941 (-43 600) | 11,37 (-0,03) | 20 451 941 (-43 600) | 0,00 | 2025-08-27 | |
| Sopharma AD | 20 495 541 (-49 801) | 11,40 (-0,03) | 20 495 541 (-49 801) | 0,00 | 2025-08-26 | |
| Sopharma AD | 20 545 342 (-303 540) | 11,43 (-0,17) | 20 545 342 (-303 540) | 0,00 | 2025-08-25 | |
| Sopharma AD | 20 848 882 (-99 775) | 11,60 (-0,05) | 20 848 882 (-99 775) | 0,00 | 2025-08-22 | |
| Sopharma AD | 20 948 657 (-17 126) | 11,65 (-0,01) | 20 948 657 (-17 126) | 0,00 | 2025-08-21 | |
| Sopharma AD | 20 965 783 (-68 049) | 11,66 (-0,04) | 20 965 783 (-68 049) | 0,00 | 2025-08-20 | |
| Sopharma AD | 21 033 832 (-3 900) | 11,70 | 21 033 832 (-3 900) | 0,00 | 2025-08-19 | |
| Sopharma AD | 21 037 732 (-1 100) | 11,70 | 21 037 732 (-1 100) | 0,00 | 2025-08-18 | |
| Sopharma AD | 21 038 832 (-333 272) | 11,70 (-0,19) | 21 038 832 (-333 272) | 0,00 | 2025-08-15 | |
| Sopharma AD | 21 372 104 | 11,89 | 21 372 104 | 0,00 | 2025-08-14 | |
| Sopharma AD | 21 372 104 (-7 450) | 11,89 | 21 372 104 (-7 450) | 0,00 | 2025-08-14 | |
| Sopharma AD | 21 379 554 (-22 617) | 11,89 (-0,01) | 21 379 554 (-22 617) | 0,00 | 2025-08-13 | |
| Sopharma AD | 21 402 171 (-9 000) | 11,90 (-0,01) | 21 402 171 (-9 000) | 0,00 | 2025-08-12 | |
| Sopharma AD | 21 411 171 (-5 499) | 11,91 | 21 411 171 (-5 499) | 0,00 | 2025-08-11 | |
| Sopharma AD | 21 416 670 (-7 300) | 11,91 (-0,01) | 21 416 670 (-7 300) | 0,00 | 2025-08-08 | |
| Sopharma AD | 21 423 970 (-8 400) | 11,92 | 21 423 970 (-8 400) | 0,00 | 2025-08-07 | |
| Sopharma AD | 21 432 370 (-6 000) | 11,92 | 21 432 370 (-6 000) | 0,00 | 2025-08-06 | |
| Sopharma AD | 21 438 370 (-3 831 544) | 11,92 (-2,14) | 21 438 370 (-3 831 544) | 0,00 | 2025-08-05 | |
| Sopharma AD | 25 269 914 (-770 286) | 14,06 (-0,42) | 25 269 914 (-770 286) | 0,00 | 2025-08-04 | |
| Sopharma AD | 26 040 200 (-17 500) | 14,48 (-0,61) | 26 040 200 (-17 500) | 0,00 | 2025-08-01 | |
| Sopharma AD | 26 057 700 | 15,09 (0,60) | 26 057 700 | 0,00 | 2025-07-31 | |
| Sopharma AD | 26 057 700 (-2 400) | 14,49 (-0,60) | 26 057 700 (-2 400) | 0,00 | 2025-07-31 | |
| Sopharma AD | 26 060 100 (-39 500) | 15,09 (-0,03) | 26 060 100 (-39 500) | 0,00 | 2025-07-30 | |
| Sopharma AD | 26 099 600 (11 000) | 15,12 (0,01) | 26 099 600 (11 000) | 0,00 | 2025-07-29 | |
| Sopharma AD | 26 088 600 (7 000) | 15,11 | 26 088 600 (7 000) | 0,00 | 2025-07-29 | |
| Sopharma AD | 26 081 600 (17 739 226) | 15,11 (10,28) | 26 081 600 (17 739 226) | 0,00 | 2025-07-29 | |
| Sopharma AD | 8 342 374 (-22 973) | 4,83 (-0,01) | 8 342 374 (-22 973) | 0,00 | 2025-07-24 | |
| Sopharma AD | 8 365 347 (-380) | 4,84 | 8 365 347 (-380) | 0,00 | 2025-07-23 | |
| Sopharma AD | 8 365 727 (-11 000) | 4,84 (-0,01) | 8 365 727 (-11 000) | 0,00 | 2025-07-22 | |
| Sopharma AD | 8 376 727 (-81 170) | 4,85 (-0,05) | 8 376 727 (-81 170) | 0,00 | 2025-07-18 | |
| Sopharma AD | 8 457 897 (-72 486) | 4,90 (-0,04) | 8 457 897 (-72 486) | 0,00 | 2025-07-17 | |
| Sopharma AD | 8 530 383 (-1 000) | 4,94 | 8 530 383 (-1 000) | 0,00 | 2025-07-16 | |
| Sopharma AD | 8 531 383 (-344 580) | 4,94 (-0,20) | 8 531 383 (-344 580) | 0,00 | 2025-07-15 | |
| Sopharma AD | 8 875 963 (-17 000) | 5,14 (-0,01) | 8 875 963 (-17 000) | 0,00 | 2025-07-14 | |
| Sopharma AD | 8 892 963 (-2 000) | 5,15 | 8 892 963 (-2 000) | 0,00 | 2025-07-11 | |
| Sopharma AD | 8 894 963 (-518 619) | 5,15 (-0,30) | 8 894 963 (-518 619) | 0,00 | 2025-07-02 | |
| Sopharma AD | 9 413 582 (-500) | 5,45 | 9 413 582 (-500) | 0,00 | 2025-07-01 | |
| Sopharma AD | 9 414 082 (-6 000) | 5,45 | 9 414 082 (-6 000) | 0,00 | 2025-06-27 | |
| Sopharma AD | 9 420 082 (-3 512 700) | 5,45 (-2,04) | 9 420 082 (-3 512 700) | 0,00 | 2025-06-26 | |
| Sopharma AD | 12 932 782 (-2 000) | 7,49 | 12 932 782 (-2 000) | 0,00 | 2025-06-23 | |
| Sopharma AD | 12 934 782 (-500) | 7,49 | 12 934 782 (-500) | 0,00 | 2025-06-20 | |
| Sopharma AD | 12 935 282 (-10 300) | 7,49 (-0,01) | 12 935 282 (-10 300) | 0,00 | 2025-06-19 | |
| Sopharma AD | 12 945 582 (-14 132) | 7,50 | 12 945 582 (-14 132) | 0,00 | 2025-06-18 | |
| Sopharma AD | 12 959 714 (-18 000) | 7,50 (-0,01) | 12 959 714 (-18 000) | 0,00 | 2025-06-17 | |
| Sopharma AD | 12 977 714 (-808) | 7,51 | 12 977 714 (-808) | 0,00 | 2025-06-16 | |
| Sopharma AD | 12 978 522 (-9 192) | 7,51 (-0,01) | 12 978 522 (-9 192) | 0,00 | 2025-06-13 | |
| Sopharma AD | 12 987 714 (-5 296) | 7,52 | 12 987 714 (-5 296) | 0,00 | 2025-06-12 | |
| Sopharma AD | 12 993 010 (-6 200) | 7,52 (-0,01) | 12 993 010 (-6 200) | 0,00 | 2025-06-11 | |
| Sopharma AD | 12 999 210 | 7,53 | 12 999 210 | 0,00 | 2025-06-10 | |
| Sopharma AD | 12 999 210 (-21 413) | 7,53 (-0,01) | 12 999 210 (-21 413) | 0,00 | 2025-06-10 | |
| Sopharma AD | 13 020 623 (-260 193) | 7,54 (-0,15) | 13 020 623 (-260 196) | 0,00 | 2025-06-09 | |
| Sopharma AD | 13 280 816 (-3 310) | 7,69 | 13 280 819 (-3 307) | 0,00 | 2025-06-06 | |
| Sopharma AD | 13 284 126 (-13 660) | 7,69 (-0,01) | 13 284 126 (-13 660) | 0,00 | 2025-06-05 | |
| Sopharma AD | 13 297 786 (-42 210) | 7,70 (-0,02) | 13 297 786 (-42 210) | 0,00 | 2025-06-04 | |
| Sopharma AD | 13 339 996 (-12 000) | 7,72 (-0,01) | 13 339 996 (-12 000) | 0,00 | 2025-06-03 | |
| Sopharma AD | 13 351 996 (-5 232) | 7,73 | 13 351 996 (-5 232) | 0,00 | 2025-06-02 | |
| Sopharma AD | 13 357 228 (-6 770) | 7,73 (-0,01) | 13 357 228 (-6 770) | 0,00 | 2024-09-05 | |
| Sopharma AD | 13 363 998 (-791 300) | 7,74 (-0,46) | 13 363 998 (-791 300) | 0,00 | 2024-06-27 | |
| Donev, Ognian Ivanov | 14 445 831 (-33 056 949) | 8,36 (-26,88) | 14 445 831 (-33 056 949) | 8,36 (-26,88) | 2024-06-14 | |
| Donev Investments Holding AD | 69 122 526 | 40,04 | 69 122 526 | 40,04 | 2024-06-14 | |
| Sopharma AD | 14 155 298 (-49 984) | 8,20 (-0,03) | 14 155 298 (-49 984) | 0,00 | 2024-06-13 | |
| Sopharma AD | 14 205 282 (-119 042) | 8,23 (-0,06) | 14 205 282 (-119 042) | 0,00 | 2024-06-12 | |
| Sopharma AD | 14 324 324 (579 988) | 8,29 (0,33) | 14 324 324 (579 988) | 0,00 | 2024-06-11 | |
| Sopharma AD | 13 744 336 (265 336) | 7,96 (-2,03) | 13 744 336 (265 336) | 0,00 | 2023-12-08 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 47 502 780 (11 727 418) | 35,24 (8,71) | 47 502 780 (11 727 418) | 35,24 (8,71) | 2023-02-21 |
| Sopharma AD | 13 479 000 (224 000) | 9,99 (0,16) | 13 479 000 (224 000) | 0,00 | 2022-06-13 | |
| Sopharma AD | 13 255 000 (200 000) | 9,83 (0,15) | 13 255 000 (200 000) | 0,00 | 2022-06-06 | |
| Rompharm Company OOD | 4 313 533 (-4 057 417) | 3,20 (-3,01) | 4 313 533 (-4 057 417) | 3,20 (-3,01) | 2021-12-07 | |
| Sopharma AD | 13 055 000 (143 533) | 9,68 (0,11) | 13 055 000 (143 533) | 0,00 | 2021-12-03 | |
| Sopharma AD | 12 911 467 (2 600 000) | 9,57 (1,93) | 12 911 467 (2 600 000) | 0,00 | 2021-12-01 | |
| Sopharma AD | 10 311 467 (200 000) | 7,64 (0,14) | 10 311 467 (200 000) | 0,00 | 2021-09-29 | |
| Sopharma AD | 10 111 467 (300 000) | 7,50 (0,23) | 10 111 467 (300 000) | 0,00 | 2021-09-24 | |
| Sopharma AD | 9 811 467 (200 000) | 7,27 (0,14) | 9 811 467 (200 000) | 0,00 | 2021-09-17 | |
| Sopharma AD | 9 611 467 (350 000) | 7,13 (0,26) | 9 611 467 (350 000) | 0,00 | 2021-09-10 | |
| Sopharma AD | 9 261 467 (250 000) | 6,87 (0,19) | 9 261 467 (250 000) | 0,00 | 2021-09-03 | |
| Rompharm Company OOD | 8 370 950 (-5 174 050) | 6,21 (-3,83) | 8 370 950 (-5 174 050) | 6,21 (-3,83) | 2020-12-31 | |
| CUPF Allianz Bulgaria | 7 049 930 | 5,22 (1,14) | 7 049 930 | 5,22 (1,14) | 2020-12-31 | |
| CUPF Allianz Bulgaria | 7 049 930 | 4,08 (-1,14) | 7 049 930 | 4,08 (-1,14) | 2020-12-31 | |
| CUPF Allianz Bulgaria | 7 049 930 | 5,22 | 7 049 930 | 5,22 | 2020-12-31 | |
| CUPF Allianz Bulgaria | 7 049 930 (188 717) | 5,22 (0,14) | 7 049 930 (188 717) | 5,22 (0,14) | 2020-12-31 | |
| Telekomplekt AD | 27 876 206 | 20,68 | 27 876 206 | 20,68 | 2020-12-30 | |
| Telekomplekt AD | 27 876 206 | 20,68 | 27 876 206 | 20,68 | 2020-12-30 | |
| Telekomplekt AD | 27 876 206 | 20,68 (4,53) | 27 876 206 | 20,68 (4,53) | 2020-12-30 | |
| Telekomplekt AD | 27 876 206 (819 454) | 16,15 (-3,92) | 27 876 206 (819 454) | 16,15 (-3,92) | 2020-12-30 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 35 775 362 | 26,53 | 35 775 362 | 26,53 | 2020-12-30 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 35 775 362 (-2 954 248) | 26,53 (-2,20) | 35 775 362 (-2 954 248) | 26,53 (-2,20) | 2020-12-30 |
| Sopharma AD | 9 011 467 (65 000) | 6,68 (0,05) | 9 011 467 (65 000) | 0,00 | 2020-09-29 | |
| Sopharma AD | 8 946 467 (-9 000) | 6,63 (-0,01) | 8 946 467 (-9 000) | 0,00 | 2020-09-25 | |
| Sopharma AD | 8 955 467 (-5 000) | 6,64 | 8 955 467 (-5 000) | 0,00 | 2020-09-24 | |
| Sopharma AD | 8 960 467 (-5 000) | 6,64 (-0,01) | 8 960 467 (-5 000) | 0,00 | 2020-09-23 | |
| Sopharma AD | 8 965 467 (-9 000) | 6,65 | 8 965 467 (-9 000) | 0,00 | 2020-09-21 | |
| Sopharma AD | 8 974 467 (-54 000) | 6,65 (-0,04) | 8 974 467 (-54 000) | 0,00 | 2020-06-30 | |
| Sopharma AD | 9 028 467 (-15 000) | 6,69 (-0,01) | 9 028 467 (-15 000) | 0,00 | 2020-06-26 | |
| Sopharma AD | 9 043 467 (-10 000) | 6,70 (-0,01) | 9 043 467 (-10 000) | 0,00 | 2020-06-25 | |
| Sopharma AD | 9 053 467 (-5 000) | 6,71 (-0,01) | 9 053 467 (-5 000) | 0,00 | 2020-06-24 | |
| Sopharma AD | 9 058 467 (-31 000) | 6,72 (-0,02) | 9 058 467 (-31 000) | 0,00 | 2020-06-22 | |
| Sopharma AD | 9 089 467 (-4 000) | 6,74 | 9 089 467 (-4 000) | 0,00 | 2020-06-19 | |
| Sopharma AD | 9 093 467 (-192 496) | 6,74 (-0,14) | 9 093 467 (-192 496) | 0,00 | 2020-06-17 | |
| Sopharma AD | 9 285 963 (171 496) | 6,88 (0,12) | 9 285 963 (171 496) | 0,00 | 2020-06-15 | |
| Sopharma AD | 9 114 467 (-85 748) | 6,76 (-0,06) | 9 114 467 (-85 748) | 0,00 | 2020-06-15 | |
| Sopharma AD | 9 200 215 (86 748) | 6,82 (0,06) | 9 200 215 (86 748) | 0,00 | 2020-06-01 | |
| Sopharma AD | 9 113 467 (800) | 6,76 | 9 113 467 (800) | 0,00 | 2019-12-20 | |
| Sopharma AD | 9 112 667 (2 000) | 6,76 (0,01) | 9 112 667 (2 000) | 0,00 | 2019-12-19 | |
| Sopharma AD | 9 110 667 (1 830) | 6,75 | 9 110 667 (1 830) | 0,00 | 2019-12-17 | |
| Sopharma AD | 9 108 837 (30 197) | 6,75 (0,02) | 9 108 837 (30 197) | 0,00 | 2019-12-16 | |
| Sopharma AD | 9 078 640 (87 640) | 6,73 (0,07) | 9 078 640 (87 640) | 0,00 | 2019-12-13 | |
| Sopharma AD | 8 991 000 (-41 320) | 6,66 (-0,04) | 8 991 000 (-41 320) | 0,00 | 2019-12-12 | |
| Sopharma AD | 9 032 320 (128 138) | 6,70 (0,10) | 9 032 320 (128 138) | 0,00 | 2019-12-12 | |
| Sopharma AD | 8 904 182 (22 350) | 6,60 (0,02) | 8 904 182 (22 350) | 0,00 | 2019-12-10 | |
| Sopharma AD | 8 881 832 (182) | 6,58 | 8 881 832 (182) | 0,00 | 2019-09-23 | |
| CUPF Allianz Bulgaria | 6 861 213 (-107 838) | 5,08 (-0,08) | 6 861 213 (-107 838) | 5,08 (-0,08) | 2019-01-23 | |
| Sopharma AD | 8 881 650 (314) | 6,58 | 8 881 650 (314) | 0,00 | 2018-12-28 | |
| Sopharma AD | 8 881 336 (3 500) | 6,58 | 8 881 336 (3 500) | 0,00 | 2018-12-21 | |
| Sopharma AD | 8 877 836 (-3 000) | 6,58 | 8 877 836 (-3 000) | 0,00 | 2018-12-18 | |
| Sopharma AD | 8 880 836 (17 000) | 6,58 (0,01) | 8 880 836 (17 000) | 0,00 | 2018-12-17 | |
| Sopharma AD | 8 863 836 (6 000) | 6,57 | 8 863 836 (6 000) | 0,00 | 2018-12-14 | |
| Sopharma AD | 8 857 836 (-1 000) | 6,57 | 8 857 836 (-1 000) | 0,00 | 2018-12-13 | |
| Sopharma AD | 8 858 836 (500) | 6,57 | 8 858 836 (500) | 0,00 | 2018-12-13 | |
| Sopharma AD | 8 858 336 (3 000) | 6,57 (0,01) | 8 858 336 (3 000) | 0,00 | 2018-12-12 | |
| Sopharma AD | 8 855 336 (5 000) | 6,56 | 8 855 336 (5 000) | 0,00 | 2018-12-11 | |
| Sopharma AD | 8 850 336 (5 620) | 6,56 | 8 850 336 (5 620) | 0,00 | 2018-12-10 | |
| Sopharma AD | 8 844 716 (-550) | 6,56 | 8 844 716 (-550) | 0,00 | 2018-12-06 | |
| Sopharma AD | 8 845 266 (1 000) | 6,56 | 8 845 266 (1 000) | 0,00 | 2018-12-05 | |
| Sopharma AD | 8 844 266 (7 000) | 6,56 (0,01) | 8 844 266 (7 000) | 0,00 | 2018-12-05 | |
| Sopharma AD | 8 837 266 (-100) | 6,55 | 8 837 266 (-100) | 0,00 | 2018-12-04 | |
| Sopharma AD | 8 837 366 (480) | 6,55 | 8 837 366 (980) | 0,00 | 2018-12-03 | |
| Sopharma AD | 8 836 886 | 6,55 | 8 836 386 (-500) | 0,00 | 2018-11-01 | |
| Sopharma AD | 8 836 886 (-9 430) | 6,55 (-0,01) | 8 836 886 (-9 430) | 0,00 | 2018-10-29 | |
| Sopharma AD | 8 846 316 (-277 400) | 6,56 (-0,20) | 8 846 316 (-277 400) | 0,00 | 2018-10-22 | |
| Sopharma AD | 9 123 716 (10 017) | 6,76 | 9 123 716 (10 017) | 0,00 | 2018-09-28 | |
| Sopharma AD | 9 113 699 (2 947) | 6,76 (0,01) | 9 113 699 (2 947) | 0,00 | 2018-09-25 | |
| Sopharma AD | 9 110 752 (-67 248) | 6,75 (-0,05) | 9 110 752 (-67 248) | 0,00 | 2018-09-21 | |
| Sopharma AD | 9 178 000 (13 000) | 6,80 (0,01) | 9 178 000 (13 000) | 0,00 | 2018-09-19 | |
| Sopharma AD | 9 165 000 (5 000) | 6,79 | 9 165 000 (5 000) | 0,00 | 2018-09-18 | |
| Sopharma AD | 9 160 000 (1 690) | 6,79 | 9 160 000 (1 690) | 0,00 | 2018-09-17 | |
| Sopharma AD | 9 158 310 (4 000) | 6,79 | 9 158 310 (4 000) | 0,00 | 2018-09-13 | |
| Sopharma AD | 9 154 310 (5 434) | 6,79 (0,01) | 9 154 310 (5 434) | 0,00 | 2018-09-12 | |
| Sopharma AD | 9 148 876 (28) | 6,78 | 9 148 876 (28) | 0,00 | 2018-09-11 | |
| Sopharma AD | 9 148 848 (538) | 6,78 | 9 148 848 (538) | 0,00 | 2018-09-10 | |
| Sopharma AD | 9 148 310 (8 500) | 6,78 | 9 148 310 (8 500) | 0,00 | 2018-06-29 | |
| Sopharma AD | 9 139 810 (233) | 6,78 | 9 139 810 (233) | 0,00 | 2018-06-28 | |
| Sopharma AD | 9 139 577 (11 857) | 6,78 (0,01) | 9 139 577 (11 857) | 0,00 | 2018-06-27 | |
| Sopharma AD | 9 127 720 (19 373) | 6,77 (0,02) | 9 127 720 (19 373) | 0,00 | 2018-06-26 | |
| Sopharma AD | 9 108 347 (28 951) | 6,75 (0,02) | 9 108 347 (28 951) | 0,00 | 2018-06-25 | |
| Sopharma AD | 9 079 396 (4 740) | 6,73 | 9 079 396 (4 740) | 0,00 | 2018-06-22 | |
| Sopharma AD | 9 074 656 (4 250) | 6,73 (0,01) | 9 074 656 (4 250) | 0,00 | 2018-06-21 | |
| Sopharma AD | 9 070 406 (2 200) | 6,72 | 9 070 406 (2 200) | 0,00 | 2018-06-20 | |
| Sopharma AD | 9 068 206 (106) | 6,72 | 9 068 206 (106) | 0,00 | 2018-06-19 | |
| Sopharma AD | 9 068 100 (2 272) | 6,72 | 9 068 100 (2 272) | 0,00 | 2018-06-15 | |
| Sopharma AD | 9 065 828 (1 000) | 6,72 | 9 065 828 (1 000) | 0,00 | 2018-06-14 | |
| Sopharma AD | 9 064 828 (24 062) | 6,72 (0,02) | 9 064 828 (24 062) | 0,00 | 2018-06-13 | |
| Sopharma AD | 9 040 766 (136 766) | 6,70 (0,10) | 9 040 766 (136 766) | 0,00 | 2018-06-04 | |
| Sopharma AD | 8 904 000 (-128 980) | 6,60 (-0,10) | 8 904 000 (-128 980) | 0,00 | 2017-12-29 | |
| Sopharma AD | 9 032 980 (10 934) | 6,70 (0,01) | 9 032 980 (10 934) | 0,00 | 2017-12-20 | |
| Sopharma AD | 9 022 046 (130 166) | 6,69 (0,10) | 9 022 046 (130 166) | 0,00 | 2017-12-15 | |
| Sopharma AD | 8 891 880 (3 000) | 6,59 | 8 891 880 (3 000) | 0,00 | 2017-12-14 | |
| Sopharma AD | 8 888 880 (6 251) | 6,59 (0,01) | 8 888 880 (6 251) | 0,00 | 2017-12-13 | |
| Rompharm Company OOD | 13 545 000 (1 000 000) | 10,04 (0,74) | 13 545 000 (1 000 000) | 10,04 (0,74) | 2017-12-08 | |
| Rompharm Company OOD | 12 545 000 (-10 685 000) | 9,30 (-8,29) | 12 545 000 (-10 685 000) | 9,30 (-8,29) | 2017-12-08 | |
| Sopharma AD | 8 882 629 (-264 156) | 6,58 (-0,20) | 8 882 629 (-264 156) | 0,00 | 2017-12-07 | |
| Sopharma AD | 9 146 785 (370 000) | 6,78 (0,27) | 9 146 785 (370 000) | 0,00 | 2017-12-06 | |
| Sopharma AD | 8 776 785 (2 691 292) | 6,51 (2,00) | 8 776 785 (2 691 292) | 0,00 | 2017-12-06 | |
| Sopharma AD | 6 085 493 (924 732) | 4,51 (0,69) | 6 085 493 (-45 522 121) | 0,00 | 2017-12-05 | |
| Sopharma AD | 5 160 761 (1 000) | 3,82 | 51 607 614 (46 447 853) | 0,00 | 2017-09-26 | |
| Sopharma AD | 5 159 761 (-169 556) | 3,82 (-0,13) | 5 159 761 (-169 556) | 0,00 | 2017-09-21 | |
| Sopharma AD | 5 329 317 (10 600) | 3,95 (0,01) | 5 329 317 (10 600) | 0,00 | 2017-09-18 | |
| Sopharma AD | 5 318 717 (15 695) | 3,94 (0,01) | 5 318 717 (15 695) | 0,00 | 2017-09-15 | |
| Sopharma AD | 5 303 022 (47 920) | 3,93 (0,04) | 5 303 022 (47 920) | 0,00 | 2017-09-14 | |
| Sopharma AD | 5 255 102 (-407 312) | 3,89 (-0,31) | 5 255 102 (-407 312) | 0,00 | 2017-09-11 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 729 610 (-3 439) | 28,73 | 38 729 610 (-3 439) | 28,73 | 2017-06-07 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 733 049 (506 439) | 28,73 (0,38) | 38 733 049 (506 439) | 28,73 (0,38) | 2017-06-07 |
| CUPF Allianz Bulgaria | 6 969 051 (250 000) | 5,16 (0,18) | 6 969 051 (250 000) | 5,16 (0,18) | 2016-11-18 | |
| CUPF Allianz Bulgaria | 6 719 051 (254 438) | 4,98 (0,19) | 6 719 051 (254 438) | 4,98 (0,19) | 2016-11-18 | |
| CUPF Allianz Bulgaria | 6 464 613 (-342 680) | 4,79 (-0,25) | 6 464 613 (-342 680) | 4,79 (-0,25) | 2016-11-11 | |
| Sopharma AD | 5 662 414 (57 328) | 4,20 (0,05) | 5 662 414 (57 328) | 0,00 | 2016-09-30 | |
| Sopharma AD | 5 605 086 (97 705) | 4,15 (0,07) | 5 605 086 (97 705) | 0,00 | 2016-09-28 | |
| Sopharma AD | 5 507 381 (27 669) | 4,08 (0,02) | 5 507 381 (27 669) | 0,00 | 2016-09-23 | |
| Sopharma AD | 5 479 712 (11 024) | 4,06 (0,01) | 5 479 712 (11 024) | 0,00 | 2016-09-14 | |
| CUPF Allianz Bulgaria | 6 807 293 | 5,04 | 6 807 293 | 5,04 | 2016-09-12 | |
| Sopharma AD | 5 468 688 (450) | 4,05 | 5 468 688 (450) | 0,00 | 2016-08-08 | |
| Sopharma AD | 5 468 238 (4 464) | 4,05 | 5 468 238 (4 464) | 0,00 | 2016-08-04 | |
| Sopharma AD | 5 463 774 (18 059) | 4,05 (0,02) | 5 463 774 (18 059) | 0,00 | 2016-08-01 | |
| Sopharma AD | 5 445 715 (46 842) | 4,03 (0,03) | 5 445 715 (-2 953 158) | 0,00 | 2016-07-14 | |
| Sopharma AD | 5 398 873 (177 577) | 4,00 (0,13) | 8 398 873 (3 177 577) | 0,00 | 2016-07-07 | |
| Sopharma AD | 5 221 296 (2 000) | 3,87 | 5 221 296 (2 000) | 0,00 | 2016-01-20 | |
| Sopharma AD | 5 219 296 (43 614) | 3,87 (0,04) | 5 219 296 (43 614) | 0,00 | 2015-09-09 | |
| Sopharma AD | 5 175 682 (500) | 3,83 | 5 175 682 (500) | 0,00 | 2015-08-23 | |
| Sopharma AD | 5 175 182 (350) | 3,83 | 5 175 182 (350) | 0,00 | 2015-08-05 | |
| Telekomplekt AD | 27 056 752 (108 700) | 20,07 (0,08) | 27 056 752 (108 700) | 20,07 (0,08) | 2015-08-03 | |
| Sopharma AD | 5 174 832 (5 000) | 3,83 | 5 174 832 (5 000) | 0,00 | 2015-07-28 | |
| Sopharma AD | 5 169 832 (500) | 3,83 | 5 169 832 (500) | 0,00 | 2015-07-15 | |
| Sopharma AD | 5 169 332 (200) | 3,83 | 5 169 332 (200) | 0,00 | 2015-06-17 | |
| Sopharma AD | 5 169 132 (5 312) | 3,83 | 5 169 132 (5 312) | 0,00 | 2015-05-27 | |
| Sopharma AD | 5 163 820 (664) | 3,83 | 5 163 820 (664) | 0,00 | 2015-04-01 | |
| Sopharma AD | 5 163 156 (15 200) | 3,83 (0,02) | 5 163 156 (15 200) | 0,00 | 2015-03-25 | |
| Sopharma AD | 5 147 956 (900) | 3,81 | 5 147 956 (900) | 0,00 | 2015-03-11 | |
| Sopharma AD | 5 147 056 (10 535) | 3,81 (-0,08) | 5 147 056 (10 535) | 0,00 | 2015-03-04 | |
| Sopharma AD | 5 136 521 | 3,89 (0,08) | 5 136 521 | 0,00 | 2015-02-13 | |
| Sopharma AD | 5 136 521 (105 943) | 3,81 | 5 136 521 (105 943) | 0,00 | 2015-02-13 | |
| Sopharma AD | 5 030 578 (30 653) | 3,81 (0,03) | 5 030 578 (30 653) | 0,00 | 2014-07-23 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 226 610 | 28,35 (-0,60) | 38 226 610 | 28,35 (-0,60) | 2014-07-18 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 226 610 (13 640) | 28,95 (0,01) | 38 226 610 (13 640) | 28,95 (0,01) | 2014-07-18 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 212 970 (-1 590) | 28,94 (-0,01) | 38 212 970 (-1 590) | 28,94 (-0,01) | 2014-07-11 |
| Sopharma AD | 4 999 925 (877) | 3,78 | 4 999 925 (877) | 0,00 | 2014-07-09 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 214 560 (2 361) | 28,95 (0,01) | 38 214 560 (2 361) | 28,95 (0,01) | 2014-07-04 |
| Sopharma AD | 4 999 048 (27 776) | 3,78 (0,02) | 4 999 048 (27 776) | 0,00 | 2014-07-02 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 212 199 (-265) | 28,94 | 38 212 199 (-265) | 28,94 | 2014-06-26 |
| Sopharma AD | 4 971 272 (19 720) | 3,76 (0,01) | 4 971 272 (19 720) | 0,00 | 2014-06-25 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 212 464 (-3 660) | 28,94 (-0,01) | 38 212 464 (-3 660) | 28,94 (-0,01) | 2014-06-20 |
| Sopharma AD | 4 951 552 (10 170) | 3,75 (0,01) | 4 951 552 (10 170) | 0,00 | 2014-06-18 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 216 124 (-2 321) | 28,95 | 38 216 124 (-2 321) | 28,95 | 2014-06-12 |
| Sopharma AD | 4 941 382 (-47 053) | 3,74 (-0,03) | 4 941 382 (-47 053) | 0,00 | 2014-06-11 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 218 445 (1 321) | 28,95 | 38 218 445 (1 321) | 28,95 | 2014-06-06 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 217 124 (1 773) | 28,95 | 38 217 124 (1 773) | 28,95 | 2014-05-29 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 215 351 (1 229) | 28,95 | 38 215 351 (1 229) | 28,95 | 2014-05-22 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 214 122 (6 659) | 28,95 (0,01) | 38 214 122 (6 659) | 28,95 (0,01) | 2014-05-16 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 207 463 (12 263) | 28,94 (0,01) | 38 207 463 (12 263) | 28,94 (0,01) | 2014-05-08 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 195 200 (-607) | 28,93 | 38 195 200 (-607) | 28,93 | 2014-04-26 |
| Sopharma AD | 4 988 435 (1 500) | 3,77 | 4 988 435 (1 500) | 0,00 | 2014-04-23 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 195 807 (920) | 28,93 | 38 195 807 (920) | 28,93 | 2014-04-23 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 194 887 (-1 000) | 28,93 | 38 194 887 (-1 000) | 28,93 | 2014-04-16 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 195 887 (900) | 28,93 | 38 195 887 (900) | 28,93 | 2014-04-15 |
| Sopharma AD | 4 986 935 (4 125) | 3,77 | 4 986 935 (4 125) | 0,00 | 2014-04-10 | |
| Sopharma AD | 4 982 810 (8 675) | 3,77 (0,01) | 4 982 810 (8 675) | 0,00 | 2014-04-09 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 194 987 (36 399) | 28,93 (0,03) | 38 194 987 (36 399) | 28,93 (0,03) | 2014-04-07 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 158 588 (18 489) | 28,90 (0,01) | 38 158 588 (18 489) | 28,90 (0,01) | 2014-04-03 |
| Sopharma AD | 4 974 135 (-51 050) | 3,76 (-0,04) | 4 974 135 (-51 050) | 0,00 | 2014-04-02 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 140 099 (-4 934) | 28,89 | 38 140 099 (-4 934) | 28,89 | 2014-03-26 |
| Sopharma AD | 5 025 185 (-7 894) | 3,80 (-0,01) | 5 025 185 (-7 894) | 0,00 | 2014-03-20 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 145 033 (-13 270) | 28,89 (-0,01) | 38 145 033 (-13 270) | 28,89 (-0,01) | 2014-03-20 |
| Sopharma AD | 5 033 079 (12 999) | 3,81 (0,01) | 5 033 079 (12 999) | 0,00 | 2014-03-19 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 158 303 (-395) | 28,90 | 38 158 303 (-395) | 28,90 | 2014-03-14 |
| Sopharma AD | 5 020 080 (818) | 3,80 | 5 020 080 (818) | 0,00 | 2014-03-12 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 158 698 (3 046) | 28,90 | 38 158 698 (3 046) | 28,90 | 2014-03-07 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 155 652 (91) | 28,90 | 38 155 652 (91) | 28,90 | 2014-02-28 |
| Sopharma AD | 5 019 262 (-8 611) | 3,80 | 5 019 262 (-8 611) | 0,00 | 2014-02-26 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 155 561 (-6 850) | 28,90 (-0,01) | 38 155 561 (-6 850) | 28,90 (-0,01) | 2014-02-19 |
| Sopharma AD | 5 027 873 (9 990) | 3,80 | 5 027 873 (9 990) | 0,00 | 2014-02-12 | |
| Universal Pension Fund Doverie AD | 5 447 538 (-3 424 005) | 4,12 (-2,60) | 5 447 538 (-3 424 005) | 4,12 (-2,60) | 2014-02-11 | |
| Rompharm Company OOD | 23 230 000 | 17,59 (0,36) | 23 230 000 | 17,59 (0,36) | 2014-02-07 | |
| Rompharm Company OOD | 23 230 000 | 17,23 | 23 230 000 | 17,23 | 2014-02-07 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 162 411 (-210 101) | 28,91 (-0,16) | 38 162 411 (-210 101) | 28,91 (-0,16) | 2014-02-07 |
| Sopharma AD | 5 017 883 (-504 703) | 3,80 (-0,38) | 5 017 883 (-504 703) | 0,00 | 2014-02-05 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 372 512 (-4 760) | 29,07 | 38 372 512 (-4 760) | 29,07 | 2014-01-31 |
| Sopharma AD | 5 522 586 (5 523) | 4,18 (0,01) | 5 522 586 (5 523) | 0,00 | 2014-01-29 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 377 272 (-7 250) | 29,07 | 38 377 272 (-7 250) | 29,07 | 2014-01-24 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 384 522 (-22 980) | 29,07 (-0,02) | 38 384 522 (-22 980) | 29,07 (-0,02) | 2014-01-17 |
| Sopharma AD | 5 517 063 (9 839) | 4,17 | 5 517 063 (9 839) | 0,00 | 2014-01-16 | |
| Sopharma AD | 5 507 224 (18 313) | 4,17 (0,02) | 5 507 224 (18 313) | 0,00 | 2014-01-15 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 407 502 (-48 405) | 29,09 (-0,04) | 38 407 502 (-48 405) | 29,09 (-0,04) | 2014-01-10 |
| Sopharma AD | 5 488 911 (34 045) | 4,15 (0,02) | 5 488 911 (34 045) | 0,00 | 2014-01-08 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 455 907 (-17 190) | 29,13 (-0,01) | 38 455 907 (-17 190) | 29,13 (-0,01) | 2013-12-27 |
| Sopharma AD | 5 454 866 (22 008) | 4,13 (0,02) | 5 454 866 (22 008) | 0,00 | 2013-12-18 | |
| Sopharma AD | 5 432 858 (9 796) | 4,11 (0,01) | 5 432 858 (9 796) | 0,00 | 2013-12-11 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 473 097 (-22 351) | 29,14 (-0,02) | 38 473 097 (-22 351) | 29,14 (-0,02) | 2013-12-06 |
| Sopharma AD | 5 423 062 (13 622) | 4,10 (0,01) | 5 423 062 (13 622) | 0,00 | 2013-12-04 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 495 448 (-3 600) | 29,16 | 38 495 448 (-3 600) | 29,16 | 2013-11-29 |
| Sopharma AD | 5 409 440 (10 019) | 4,09 | 5 409 440 (10 019) | 0,00 | 2013-11-27 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 499 048 (-63 200) | 29,16 (-0,05) | 38 499 048 (-63 200) | 29,16 (-0,05) | 2013-11-21 |
| Sopharma AD | 5 399 421 (7 840) | 4,09 (0,01) | 5 399 421 (7 840) | 0,00 | 2013-11-20 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 562 248 (-17 242) | 29,21 (-0,01) | 38 562 248 (-17 242) | 29,21 (-0,01) | 2013-11-15 |
| Sopharma AD | 5 391 581 (23 166) | 4,08 (0,02) | 5 391 581 (23 166) | 0,00 | 2013-11-13 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 579 490 (-26 500) | 29,22 (-0,02) | 38 579 490 (-26 500) | 29,22 (-0,02) | 2013-11-01 |
| Sopharma AD | 5 368 415 (17 612) | 4,06 (0,01) | 5 368 415 (17 612) | 0,00 | 2013-10-31 | |
| Sopharma AD | 5 350 803 (18 733) | 4,05 (0,02) | 5 350 803 (18 733) | 0,00 | 2013-10-30 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 605 990 (-24 900) | 29,24 (-0,02) | 38 605 990 (-24 900) | 29,24 (-0,02) | 2013-10-25 |
| Sopharma AD | 5 332 070 (34 425) | 4,03 (0,02) | 5 332 070 (34 425) | 0,00 | 2013-10-23 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 630 890 (-2 509) | 29,26 | 38 630 890 (-2 509) | 29,26 | 2013-10-17 |
| Sopharma AD | 5 297 645 (7 650) | 4,01 (0,01) | 5 297 645 (7 650) | 0,00 | 2013-10-16 | |
| Sopharma AD | 5 289 995 (42 014) | 4,00 (0,03) | 5 289 995 (42 014) | 0,00 | 2013-10-09 | |
| Sopharma AD | 5 247 981 (13 735) | 3,97 (0,01) | 5 247 981 (13 735) | 0,00 | 2013-10-02 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 633 399 (-9 500) | 29,26 (-0,01) | 38 633 399 (-9 500) | 29,26 (-0,01) | 2013-09-27 |
| Sopharma AD | 5 234 246 (14 524) | 3,96 (0,01) | 5 234 246 (14 524) | 0,00 | 2013-09-25 | |
| Sopharma AD | 5 219 722 (4 005) | 3,95 | 5 219 722 (4 005) | 0,00 | 2013-09-18 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 642 899 (-1 226) | 29,27 | 38 642 899 (-1 226) | 29,27 | 2013-09-13 |
| Sopharma AD | 5 215 717 (2 300) | 3,95 (0,01) | 5 215 717 (2 300) | 0,00 | 2013-09-11 | |
| Sopharma AD | 5 213 417 (19 248) | 3,94 (0,01) | 5 213 417 (19 248) | 0,00 | 2013-09-04 | |
| Sopharma AD | 5 194 169 (-15 998) | 3,93 (-0,01) | 5 194 169 (-15 998) | 0,00 | 2013-08-30 | |
| Sopharma AD | 5 210 167 (7 616) | 3,94 | 5 210 167 (7 616) | 0,00 | 2013-08-28 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 644 125 (-8 500) | 29,27 (-0,01) | 38 644 125 (-8 500) | 29,27 (-0,01) | 2013-08-23 |
| Sopharma AD | 5 202 551 (82 939) | 3,94 (0,07) | 5 202 551 (82 939) | 0,00 | 2013-08-21 | |
| Sopharma AD | 5 119 612 (19 523) | 3,87 (0,01) | 5 119 612 (19 523) | 0,00 | 2013-08-14 | |
| Sopharma AD | 5 100 089 (185 367) | 3,86 (0,14) | 5 100 089 (185 367) | 0,00 | 2013-08-07 | |
| Sopharma AD | 4 914 722 (276 414) | 3,72 (0,21) | 4 914 722 (276 414) | 0,00 | 2013-07-31 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 652 625 (-21 935) | 29,28 (-0,01) | 38 652 625 (-21 935) | 29,28 (-0,01) | 2013-07-29 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 674 560 (-35 923) | 29,29 (-0,03) | 38 674 560 (-35 923) | 29,29 (-0,03) | 2013-07-26 |
| Sopharma AD | 4 638 308 (161 424) | 3,51 (0,12) | 4 638 308 (161 424) | 0,00 | 2013-07-24 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 710 483 (-7 260) | 29,32 (-0,01) | 38 710 483 (-7 260) | 29,32 (-0,01) | 2013-07-19 |
| Sopharma AD | 4 476 884 (70 302) | 3,39 (0,06) | 4 476 884 (70 302) | 0,00 | 2013-07-17 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 717 743 (-89 210) | 29,33 (-0,06) | 38 717 743 (-89 210) | 29,33 (-0,06) | 2013-07-12 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 806 953 (-3 500) | 29,39 (-0,01) | 38 806 953 (-3 500) | 29,39 (-0,01) | 2013-07-04 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 810 453 (-9 254) | 29,40 | 38 810 453 (-9 254) | 29,40 | 2013-06-28 |
| Sopharma AD | 4 406 582 (11 210) | 3,33 (0,01) | 4 406 582 (11 210) | 0,00 | 2013-06-26 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 819 707 (-146 800) | 29,40 (-0,12) | 38 819 707 (-146 800) | 29,40 (-0,12) | 2013-06-21 |
| Sopharma AD | 4 395 372 (70 285) | 3,32 (0,05) | 4 395 372 (70 285) | 0,00 | 2013-06-19 | |
| Sopharma AD | 4 325 087 (46 607) | 3,27 (0,03) | 4 325 087 (46 607) | 0,00 | 2013-06-06 | |
| Sopharma AD | 4 278 480 (77 078) | 3,24 (0,06) | 4 278 480 (77 078) | 0,00 | 2013-06-05 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 966 507 (2 000) | 29,52 (0,01) | 38 966 507 (2 000) | 29,52 (0,01) | 2013-05-31 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 38 964 507 (-38 807) | 29,51 (-0,03) | 38 964 507 (-38 807) | 29,51 (-0,03) | 2013-05-31 |
| Sopharma AD | 4 201 402 (24 881) | 3,18 (0,02) | 4 201 402 (24 881) | 0,00 | 2013-05-23 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 003 314 (-25 400) | 29,54 (-0,02) | 39 003 314 (-25 400) | 29,54 (-0,02) | 2013-05-23 |
| Sopharma AD | 4 176 521 (48 520) | 3,16 (0,04) | 4 176 521 (48 520) | 0,00 | 2013-05-22 | |
| Sopharma AD | 4 128 001 (14 244) | 3,12 (0,01) | 4 128 001 (14 244) | 0,00 | 2013-05-15 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 028 714 (-7 000) | 29,56 (-0,01) | 39 028 714 (-7 000) | 29,56 (-0,01) | 2013-05-14 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 035 714 (-396) | 29,57 | 39 035 714 (-396) | 29,57 | 2013-05-13 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 036 110 (-63 000) | 29,57 (-0,05) | 39 036 110 (-63 000) | 29,57 (-0,05) | 2013-05-10 |
| Sopharma AD | 4 113 757 (108 089) | 3,11 (0,08) | 4 113 757 (108 089) | 0,00 | 2013-05-08 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 099 110 (2 000) | 29,62 (0,01) | 39 099 110 (2 000) | 29,62 (0,01) | 2013-04-29 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 097 110 (-26 520) | 29,61 (-0,02) | 39 097 110 (-26 520) | 29,61 (-0,02) | 2013-04-26 |
| Sopharma AD | 4 005 668 (140 703) | 3,03 (0,11) | 4 005 668 (140 703) | 0,00 | 2013-04-24 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 123 630 (-28 050) | 29,63 (-0,03) | 39 123 630 (-28 050) | 29,63 (-0,03) | 2013-04-18 |
| Sopharma AD | 3 864 965 (158 132) | 2,92 (0,12) | 3 864 965 (158 132) | 0,00 | 2013-04-17 | |
| Sopharma AD | 3 706 833 (39 486) | 2,80 (0,03) | 3 706 833 (39 486) | 0,00 | 2013-04-10 | |
| Sopharma AD | 3 667 347 (1 000) | 2,77 | 3 667 347 (1 000) | 0,00 | 2013-04-03 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 151 680 (-100 000) | 29,66 (-0,07) | 39 151 680 (-100 000) | 29,66 (-0,07) | 2013-04-01 |
| Sopharma AD | 3 666 347 (13 480) | 2,77 (0,01) | 3 666 347 (13 480) | 0,00 | 2013-03-27 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 251 680 (-5 100) | 29,73 | 39 251 680 (-5 100) | 29,73 | 2013-03-22 |
| Sopharma AD | 3 652 867 (31 768) | 2,76 (0,02) | 3 652 867 (31 768) | 0,00 | 2013-03-20 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 256 780 (-1 000) | 29,73 (-0,01) | 39 256 780 (-1 000) | 29,73 (-0,01) | 2013-03-15 |
| Sopharma AD | 3 621 099 (7 941) | 2,74 (0,01) | 3 621 099 (7 941) | 0,00 | 2013-03-06 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 257 780 (-300) | 29,74 | 39 257 780 (-300) | 29,74 | 2013-03-05 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 258 080 (7 339) | 29,74 (0,01) | 39 258 080 (7 339) | 29,74 (0,01) | 2013-02-28 |
| Sopharma AD | 3 613 158 (29 950) | 2,73 (0,02) | 3 613 158 (29 950) | 0,00 | 2013-02-27 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 250 741 (6 800) | 29,73 | 39 250 741 (6 800) | 29,73 | 2013-02-21 |
| Sopharma AD | 3 583 208 (9 400) | 2,71 (0,01) | 3 583 208 (9 400) | 0,00 | 2013-02-20 | |
| Sopharma AD | 3 573 808 (13 439) | 2,70 (0,01) | 3 573 808 (13 439) | 0,00 | 2013-02-13 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 243 941 (-3 500) | 29,73 | 39 243 941 (-3 500) | 29,73 | 2013-02-11 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 247 441 (-4 000) | 29,73 | 39 247 441 (-4 000) | 29,73 | 2013-02-08 |
| Sopharma AD | 3 560 369 (18 198) | 2,69 (0,01) | 3 560 369 (18 198) | 0,00 | 2013-02-06 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 251 441 (-21 650) | 29,73 (-0,02) | 39 251 441 (-21 650) | 29,73 (-0,02) | 2013-01-31 |
| Sopharma AD | 3 542 171 (30 477) | 2,68 (0,02) | 3 542 171 (30 477) | 0,00 | 2013-01-30 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 273 091 (-305 598) | 29,75 (-0,23) | 39 273 091 (-305 598) | 29,75 (-0,23) | 2013-01-25 |
| Pavlov, Liubomir Vladimirov | poprzez Financial Consulting Company EOOD | 17 387 853 | 12,89 (-0,28) | 17 387 853 | 12,89 (-0,28) | 2013-01-23 |
| Pavlov, Liubomir Vladimirov | poprzez Financial Consulting Company EOOD | 17 387 853 (-4 053 002) | 13,17 (-3,07) | 17 387 853 (-4 053 002) | 13,17 (-3,07) | 2013-01-23 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 578 689 (2 300) | 29,98 | 39 578 689 (2 300) | 29,98 | 2013-01-23 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 39 576 389 (2 980 366) | 29,98 (2,26) | 39 576 389 (2 980 366) | 29,98 (2,26) | 2013-01-23 |
| Sopharma AD | 3 511 694 (20 763) | 2,66 (0,02) | 3 511 694 (20 763) | 0,00 | 2013-01-17 | |
| Sopharma AD | 3 490 931 (1 000) | 2,64 | 3 490 931 (1 000) | 0,00 | 2013-01-16 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 596 023 (-1 045) | 27,72 | 36 596 023 (-1 045) | 27,72 | 2013-01-11 |
| Sopharma AD | 3 489 931 (2 000) | 2,64 | 3 489 931 (2 000) | 0,00 | 2013-01-09 | |
| Sopharma AD | 3 487 931 (1 700) | 2,64 | 3 487 931 (1 700) | 0,00 | 2013-01-02 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 597 068 (-7 945) | 27,72 (-0,01) | 36 597 068 (-7 945) | 27,72 (-0,01) | 2012-12-15 |
| Sopharma AD | 3 486 231 (50 861) | 2,64 (0,04) | 3 486 231 (50 861) | 0,00 | 2012-12-05 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 605 013 (-6 540) | 27,73 | 36 605 013 (-6 540) | 27,73 | 2012-11-29 |
| Sopharma AD | 3 435 370 (6 010) | 2,60 (0,01) | 3 435 370 (6 010) | 0,00 | 2012-11-28 | |
| Sopharma AD | 3 429 360 (220 985) | 2,59 (0,16) | 3 429 360 (220 985) | 0,00 | 2012-11-21 | |
| Sopharma AD | 3 208 375 (-219 514) | 2,43 (-0,16) | 3 208 375 (-219 514) | 0,00 | 2012-11-17 | |
| Sopharma AD | 3 427 889 (56 111) | 2,59 (0,04) | 3 427 889 (56 111) | 0,00 | 2012-11-14 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 611 553 (1 234) | 27,73 | 36 611 553 (1 234) | 27,73 | 2012-11-08 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 610 319 (-8 544) | 27,73 (-0,01) | 36 610 319 (-8 544) | 27,73 (-0,01) | 2012-11-02 |
| Sopharma AD | 3 371 778 (162 303) | 2,55 (0,12) | 3 371 778 (162 303) | 0,00 | 2012-10-31 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 618 863 (-83) | 27,74 | 36 618 863 (-83) | 27,74 | 2012-10-26 |
| Sopharma AD | 3 209 475 (2 200) | 2,43 (0,01) | 3 209 475 (2 200) | 0,00 | 2012-10-25 | |
| Sopharma AD | 3 207 275 (1 020) | 2,42 | 3 207 275 (1 020) | 0,00 | 2012-10-10 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 618 946 (-800) | 27,74 | 36 618 946 (-800) | 27,74 | 2012-10-10 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 619 746 (4 046 168) | 27,74 (3,07) | 36 619 746 (15 046 168) | 27,74 (11,40) | 2012-10-05 |
| Sopharma AD | 3 206 255 (600) | 2,42 | 3 206 255 (600) | 0,00 | 2012-09-27 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 573 578 (-4 046 768) | 24,67 (-3,07) | 21 573 578 (-15 046 768) | 16,34 (-11,40) | 2012-09-27 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 36 620 346 (4 046 420) | 27,74 (3,07) | 36 620 346 (4 046 420) | 27,74 (3,07) | 2012-09-27 |
| Sopharma AD | 3 205 655 (400) | 2,42 | 3 205 655 (400) | 0,00 | 2012-09-26 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 573 926 (1 378) | 24,67 | 32 573 926 (1 378) | 24,67 | 2012-09-20 |
| Sopharma AD | 3 205 255 (350) | 2,42 | 3 205 255 (350) | 0,00 | 2012-09-19 | |
| Sopharma AD | 3 204 905 (100) | 2,42 | 3 204 905 (100) | 0,00 | 2012-09-12 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 572 548 (11 375) | 24,67 (0,01) | 32 572 548 (11 375) | 24,67 (0,01) | 2012-09-12 |
| Sopharma AD | 3 204 805 (18 746) | 2,42 (0,01) | 3 204 805 (18 746) | 0,00 | 2012-09-05 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 561 173 (-2 600) | 24,66 | 32 561 173 (-2 600) | 24,66 | 2012-08-31 |
| Sopharma AD | 3 186 059 (10 111) | 2,41 (0,01) | 3 186 059 (10 111) | 0,00 | 2012-08-29 | |
| Sopharma AD | 3 175 948 (11 650) | 2,40 (0,01) | 3 175 948 (11 650) | 0,00 | 2012-08-22 | |
| Sopharma AD | 3 164 298 (2 200) | 2,39 | 3 164 298 (2 200) | 0,00 | 2012-08-15 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 563 773 (870) | 24,66 | 32 563 773 (870) | 24,66 | 2012-08-10 |
| Sopharma AD | 3 162 098 (4 266) | 2,39 | 3 162 098 (4 266) | 0,00 | 2012-08-08 | |
| Sopharma AD | 3 157 832 (10 615) | 2,39 (0,01) | 3 157 832 (10 615) | 0,00 | 2012-08-01 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 562 903 (-34 200) | 24,66 (-0,03) | 32 562 903 (-34 200) | 24,66 (-0,03) | 2012-07-31 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 597 103 (-2 025) | 24,69 | 32 597 103 (-2 025) | 24,69 | 2012-07-25 |
| Sopharma AD | 3 147 217 (3 435) | 2,38 | 3 147 217 (3 435) | 0,00 | 2012-07-19 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 599 128 (1 000) | 24,69 | 32 599 128 (1 000) | 24,69 | 2012-07-17 |
| Universal Pension Fund Doverie AD | 8 871 543 | 6,72 | 8 871 543 | 6,72 | 2012-06-30 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 598 128 (900) | 24,69 | 32 598 128 (900) | 24,69 | 2012-06-29 |
| Sopharma AD | 3 143 782 (15 033) | 2,38 (0,01) | 3 143 782 (15 033) | 0,00 | 2012-06-27 | |
| Sopharma AD | 3 128 749 (9 786) | 2,37 (0,01) | 3 128 749 (9 786) | 0,00 | 2012-06-20 | |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 597 228 (1 870) | 24,69 | 32 597 228 (1 870) | 24,69 | 2012-06-15 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 595 358 (4 140) | 24,69 | 32 595 358 (4 140) | 24,69 | 2012-06-08 |
| Sopharma AD | 3 118 963 (900) | 2,36 | 3 118 963 (900) | 0,00 | 2012-06-06 | |
| Sopharma AD | 3 118 063 (300) | 2,36 | 3 118 063 (300) | 0,00 | 2012-05-30 | |
| Sopharma AD | 3 117 763 | 2,36 | 3 117 763 | 0,00 | 2012-05-23 | |
| Gramercy Select Master Fund | 0 (-8 382 000) | 0,00 (-6,35) | 0 (-8 382 000) | 0,00 (-6,35) | 2012-04-09 | |
| Gramercy Emerging Markets Fund | 0 | 0,00 | 0 | 0,00 | 2012-04-09 | |
| Teksta Corporation Delaware | poprzez Telso AD | 0 (-7 073 344) | 0,00 (-5,35) | 0 (-7 073 344) | 0,00 (-5,35) | 2012-03-31 |
| Gramercy Select Master Fund | 8 382 000 | 6,35 | 8 382 000 | 6,35 | 2012-03-31 | |
| Gramercy Emerging Markets Fund | wraz z Gramercy Select Master Fund | 0 (-7 774 800) | 0,00 (-5,89) | 0 (-7 774 800) | 0,00 (-5,89) | 2012-03-31 |
| Gramercy Emerging Markets Fund | 7 774 800 (-795 237) | 5,89 (-0,60) | 7 774 800 (-795 237) | 5,89 (-0,60) | 2012-03-31 | |
| Telekomplekt AD | 26 948 052 | 19,99 (-0,42) | 26 948 052 | 19,99 (-0,42) | 2011-11-24 | |
| Telekomplekt AD | 26 948 052 | 20,41 | 26 948 052 | 20,41 | 2011-11-24 | |
| Teksta Corporation Delaware | poprzez Telso AD | 7 073 344 | 5,35 | 7 073 344 | 5,35 | 2011-11-24 |
| Pavlov, Liubomir Vladimirov | poprzez Financial Consulting Company EOOD | 21 440 855 | 16,24 | 21 440 855 | 16,24 | 2011-11-24 |
| Gramercy Emerging Markets Fund | wraz z Gramercy Select Master Fund | 8 570 037 | 6,49 | 8 570 037 | 6,49 | 2011-11-24 |
| Donev, Ognian Ivanov | wraz z Donev Investments Holding | 32 591 218 | 24,69 | 32 591 218 | 24,69 | 2011-11-24 |
Operacje na akcjach
| Data operacji | Rodzaj operacji | Komentarz |
|---|---|---|
| 2025-08-25 | Wypłata dywidendy | Dywidenda na akcję: 0,17 zł |
| 2025-07-10 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,17 zł |
| 2024-12-23 | Wypłata dywidendy | Dywidenda na akcję: 0,17 zł |
| 2024-11-08 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,17 zł |
| 2024-08-26 | Wypłata dywidendy | Dywidenda na akcję: 0,20 zł |
| 2024-07-12 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,20 zł |
| 2024-01-22 | Wypłata dywidendy | Dywidenda na akcję: 2,00 zł |
| 2023-12-08 | Nabycie praw do dywidendy | Dywidenda na akcję: 2,00 zł |
| 2023-06-16 | Wypłata dywidendy | Dywidenda na akcję: 1,39 zł |
| 2023-06-12 | Nabycie praw do dywidendy | Dywidenda na akcję: 1,39 zł |
| 2020-11-23 | Wypłata dywidendy | Dywidenda na akcję: 0,09 zł |
| 2020-10-09 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,09 zł |
| 2020-08-03 | Wypłata dywidendy | Dywidenda na akcję: 0,16 zł |
| 2020-06-19 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,16 zł |
| 2019-12-27 | Wypłata dywidendy | Dywidenda na akcję: 0,11 zł |
| 2019-12-23 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,11 zł |
| 2018-10-22 | Wypłata dywidendy | Dywidenda na akcję: 0,11 zł |
| 2018-09-28 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,11 zł |
| 2018-07-23 | Wypłata dywidendy | Dywidenda na akcję: 0,24 zł |
| 2018-06-29 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,24 zł |
| 2017-07-24 | Wypłata dywidendy | Dywidenda na akcję: 0,21 zł |
| 2017-06-16 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,21 zł |
| 2016-08-03 | Wypłata dywidendy | Dywidenda na akcję: 0,16 zł |
| 2016-07-01 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,16 zł |
| 2014-09-16 | Wypłata dywidendy | Dywidenda na akcję: 0,12 zł |
| 2014-07-04 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,12 zł |
| 2013-07-30 | Wypłata dywidendy | Dywidenda na akcję: 0,15 zł |
| 2013-07-05 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,15 zł |
| 2012-09-03 | Wypłata dywidendy | Dywidenda na akcję: 0,15 zł |
| 2012-07-03 | Nabycie praw do dywidendy | Dywidenda na akcję: 0,15 zł |
Bankier na skróty
- Kurs Euro
- Kurs dolar
- Kurs frank
- Kurs funt
- Wiron
- Przelicznik walut
- Kantor internetowy
- Kalkulator wynagrodzeń
- Umowa zlecenie
- Kredyt na mieszkanie
- Kredyt na samochód
- Kalkulator kredytowy
- Revolut
- Winiety
- Jak grać na giełdzie?
- Jak wziąć kredyt hipoteczny?
- Rejestracja samochodu
- Jak rozwiązać umowę z Orange
- Koszty uzyskania przychodów
- Sesje elixir
- PB weekend
- RRSO co to jest?
- Blogbank.pl
- Promocje bankowe - zgarnijpremie.pl
- Stopa procentowa
